Respiratory Syncytial Virus Diagnostics Market : Industry Analysis, Share, Segmentation, Price Trends, Regional Analysis and Forecast 2032
The Global Respiratory Syncytial Virus (RSV) diagnostics market size was USD 923.0 Million in 2022 and is expected to register a steady revenue CAGR of 10.9% during the forecast period, according to latest analysis by Emergen Research. Rising prevalence of respiratory infections and demand for Point-Of-Care (POC) devices and increasing neonatal population are major factors driving market revenue growth. RSV is a mild infection affecting the upper respiratory tract of young children. The common symptoms of RSV include cough, sore throat, wheezing, and runny nose. Upper Respiratory Infections (URIs) is the most frequent disorder. According to the National Health Portal of India, 41,996,260 instances of respiratory infections and 3,740 deaths were documented in India. India accounts for 18% of the world's population, with Severe Acute Respiratory Infection (SARI) being one of the leading causes of death. In addition, increasing investments into healthcare infrastructure and produ